CRNX·22663K107·US·equity·Healthcare - Biotechnology-13D/G
CRNX (CRINETICS PHARMACEUTICALS IN) is held by 131 institutional investors as of Q1 2026. Largest holders: FMR LLC ($572.4M), BlackRock, Inc. ($308M), FARALLON CAPITAL MANAGEMENT LLC ($302.8M). Net institutional sentiment: Bullish.
See how CRNX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer